EUVIMEDEUVIMED entdecken
FallberichtÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Hemostatic rescue with rFVIIa in Bernard–Soulier syndrome refractory to HLA-matched platelet transfusion

Yusuke Okamoto, Chisaki Mizumoto, Kouhei Yamashita, Seita Inoue, Susumu Saito, Naoki Morimoto, Akifumi Takaori-Kondo

Annals of Hematology · 2026

DOI: 10.1007/s00277-026-06902-8 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Annals of Hematology, 2026. Verfasst von Yusuke Okamoto und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Graduate School of Medicine, Kyoto University, Yoshidakonoe-Cho, Sakyo-Ku, KyotoKyoto, 606-8303, Japan. okamotoy@kuhp.kyoto…. Hauptthemen laut MEDLINE: Factor VIIa, Platelet Transfusion, Bernard-Soulier Syndrome, HLA Antigens. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: FY2025 Kyoto University Hospital Research Fund for Young Scientists.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We report the case of a man in his 50’s diagnosed with Bernard-Soulier syndrome (BSS) in childhood who developed refractory gluteal bleeding following a fall accident. The patient underwent four hematoma evacuation procedures and multiple platelet transfusions, including HLA (human leukocyte antigen) -matched platelet concentrates, without achieving sustained hemostatic control. Given the lack of response to platelet transfusion and ongoing bleeding risk, Eptacog Alfa (recombinant activated factor VII; rFVIIa) was administered for 4 days, following the dosing regimen recommended for Glanzmann thrombasthenia in surgical bleeding settings. Hemostasis was achieved shortly after rFVIIa administration, and no further surgical evacuation was necessary. Importantly, no thromboembolic complications occurred despite the use of rFVIIa. This case demonstrates that rFVIIa can serve as an effective adjunctive hemostatic therapy in patients with BSS who are refractory to platelet transfusions. We reviewed the existing literature on rFVIIa use in patients with BSS and summarized the clinical contexts, dosing strategies, efficacy, and safety outcomes. Our experience suggests that early consideration of rFVIIa may help prevent repeated surgical interventions and reduce bleeding-related morbidity in complex cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Factor VIIaPlatelet TransfusionBernard-Soulier SyndromeHLA AntigensHemorrhageHemostaticsHumansMaleRecombinant ProteinsMiddle Aged

Stichwörter der Autor:innen

Bernard-Soulier syndromeGluteal hematomaHLA-matched platelet transfusionRecombinant activated factor VIITransfusion refractory

Substanzen

Factor VIIarecombinant FVIIaRecombinant ProteinsHLA AntigensHemostatics

Autor:innen und Institutionen

  • Department of Hematology, Graduate School of Medicine, Kyoto University, Yoshidakonoe-Cho, Sakyo-Ku, KyotoKyoto, 606-8303, Japan. okamotoy@kuhp.kyoto-u.ac.jp.
  • Department of Hematology, Graduate School of Medicine, Kyoto University, Yoshidakonoe-Cho, Sakyo-Ku, KyotoKyoto, 606-8303, Japan.
  • Department of Plastic and Reconstructive Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Förderung

  • FY2025 Kyoto University Hospital Research Fund for Young Scientists

Zitieren

APA

Okamoto, Y., Mizumoto, C., Yamashita, K., Inoue, S., Saito, S., Morimoto, N., & Takaori-Kondo, A. (2026). Hemostatic rescue with rFVIIa in Bernard–Soulier syndrome refractory to HLA-matched platelet transfusion. Annals of Hematology. https://doi.org/10.1007/s00277-026-06902-8

Vancouver

Okamoto Y, Mizumoto C, Yamashita K, Inoue S, Saito S, Morimoto N, et al. Hemostatic rescue with rFVIIa in Bernard–Soulier syndrome refractory to HLA-matched platelet transfusion. Annals of Hematology. 2026. doi:10.1007/s00277-026-06902-8

BibTeX
@article{Okamoto2026,
  author = {Okamoto, Yusuke and Mizumoto, Chisaki and Yamashita, Kouhei and Inoue, Seita and Saito, Susumu and Morimoto, Naoki and Takaori-Kondo, Akifumi},
  title = {Hemostatic rescue with rFVIIa in Bernard–Soulier syndrome refractory to HLA-matched platelet transfusion},
  journal = {Annals of Hematology},
  year = {2026},
  doi = {10.1007/s00277-026-06902-8}
}
Kostenlos starten →